Diagnostic Imaging for Clear Cell Renal Cell Carcinoma
Status:
Terminated
Trial end date:
2018-09-12
Target enrollment:
Participant gender:
Summary
The main objective is to study whether imaging detection of the biomarker DAT can be used to
detect kidney tumors identified by computer tomography (CT), which are pathologically
assesses as being of the clear cell subtype.